In this Phase II proposal, the contractor proposes to complete the development of a multiplex molecular diagnostic assay system the can report the presence or absence of
at least 16 proteins or 20 DNA targets relevant to cancer in a single test.
IC Name
NATIONAL CANCER INSTITUTE
-
Activity
N44
-
Administering IC
CA
-
Application Type
-
Direct Cost Amount
-
Indirect Cost Amount
-
Total Cost
749999
-
Sub Project Total Cost
-
ARRA Funded
False
-
CFDA Code
394
-
Ed Inst. Type
-
Funding ICs
NCI:749999\
-
Funding Mechanism
Contracts, Extramural
-
Study Section
-
Study Section Name